Publications

DRUG STABILITY
Investigation of meropenem stability after reconstitution: the influence of buffering and challenges to meet the NHS Yellow Cover Document compliance for continuous infusions in an outpatient setting.
Authors: Conor Jamieson, Michael Charles Allwood, Donata Stonkute, Andrew Wallace, Alan-Shaun Wilkinson, Tim Hills, on behalf of the BSAC Drug Stability Working Party
Journal: European Journal of Hospital, 2018;0:1–5. doi:10.1136/ejhpharm-2018-001699

Assessment of the stability of citrate-buffered flucloxacillin for injection when stored in two commercially available ambulatory elastomeric devices: INfusor LV (Baxter) and Accufuser (Woo Young Medical): a study compliant with the NHS Yellow Cover Document (YCD) requirements.
Authors: Michael Charles Allwood, Donata Stonkute, Andrew Wallace, Alan-Shaun Wilkinson, Tim Hills, and Conor Jamieson on behalf of the BSAC Drug Stability Working Party.
Journal: European Journal of Hospital, 2018. 0:1–5. doi:10.1136/ejhpharm-2018-001515

EXTENDED STABILITY OF ANTIMICROBIAL AGENTS IN ADMINISTRATION DEVICES
Author: Abi Jenkins; Tim Hills; Mark Santillo; Mark Gilchrist; Journal of Antimicrobial Chemotherapy 2017; doi: 10.1093/jac/dkw556

Presented at the BSAC OPAT Conference, 13th-14th December 2018:
OPAT Flow Rate POSTER
Title: Outcomes of a National Survey of Experience with Continuous Infusion Elastomeric Devices in OPAT
Authors: Tim Hills, Conor Jamieson, Mark Gilchrist, Carolyne Horner, Andrew Seaton, on behalf of the UK OPAT Initiative Drug and Stability Working Group.

Presented at the BSAC OPAT Conference, 11th-12th December 2017:
Flucloxacillin POSTER
Title: Assessment of the stability of citrate-buffered Flucloxacillin for injection when stored in two commercially available ambulatory devices: INfusor (Baxter) and Accufuser® (Woo Young Medical), a study compliant with the NHS Yellow Cover Document (YCD) requirements
Authors: Tim Hills MRPharmS Michael Charles Allwood PhD, Donata Stonkute BSc, Andrew Wallace PhD, Alan-Shaun Wilkinson PhD, on behalf of the BSAC Drug Stability Working Party.

Meropenem POSTER
Title: The influence of pH and buffering on the stability of Meropenem 6.25-25 mg/ml at 32C
Authors: Tim Hills MRPharmS Michael Charles Allwood PhD, Donata Stonkute BSc, Andrew Wallace PhD, Alan-Shaun Wilkinson PhD, on behalf of the BSAC Drug Stability Working Party.

OPAT Guidance Document
Title: Guidance on the pharmaceutical issues concerning OPAT Services and other outpatient intravenous therapies
Authors: Mark Santillo, Abi Jenkins, Conor Jamieson on behalf of the NHS Pharmaceutical Quality Assurance Committee

 
GOOD PRACTICE RECOMMENDATIONS
Coming Soon: Updated (2019) Good Practice Recommendations for outpatient parenteral antimicrobial therapy (OPAT) in adults and children in the UK and associated assessment tool.

GOOD PRACTICE RECOMMENDATIONS FOR OUTPATIENT PARENTERAL ANTIMICROBIAL THERAPY (OPAT) IN ADULTS IN THE UK: A CONSENSUS STATEMENT

GOOD PRACTICE RECOMMENDATIONS FOR PAEDIATRIC OUTPATIENT PARENTERAL ANTIBIOTIC THERAPY (P-OPAT) IN THE UK: A CONSENSUS STATEMENT

 
PAEDIATRIC SUPPORT RESOURCES
The following resources are reproduced with the kind permission of Southampton Children’s Hospital OPAT Service.

Parent-carer-PICC-guidance
Infusion-Aseptic-No-Touch-technique
Parent-carer-CVC-guidance
Hand-washing-technique
Ground-rules-for-parents-carers
Competency-checklist-for-parents-carers
Community-Nurse-Template
Cribb-sheet-for-registrars
Bolus-dose-Aseptic-No-Touch-Technique

Inclusion of the above resources does not imply BSAC endorsement or approval
HOW IS INCOME GENERATED BY OUTPATIENT PARENTERAL ANTIBIOTIC TREATMENT (OPAT) IN THE UK? Analysis of payment tariffs for cellulitis